# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
-Collaboration with NKI and Funding Support for New Colorectal Cancer Clinical Trial by Major Pharma Company--Distinguished Onc...
LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune Systemby Disrupting the Process of RNA Splicing
https://register.epo.org/application?number=EP20167812
-SEC Filing
White Diamond on X: "BREAKING NEWS: Lixte Biotechnology Lied: Its Publication Yesterday Isn't New – It's The Same O...
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index gaining over 300 points on Wednesday. The...